190 related articles for article (PubMed ID: 15819171)
1. Effect of heparins on thrombin generation in hemophilic plasma supplemented with FVIII, FVIIa, or FEIBA.
Parmar N; Berry LR; Paredes N; Chan AK
Clin Lab; 2005; 51(3-4):157-66. PubMed ID: 15819171
[TBL] [Abstract][Full Text] [Related]
2. Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay.
Turecek PL; Váradi K; Keil B; Negrier C; Berntorp E; Astermark J; Bordet JC; Morfini M; Linari S; Schwarz HP
Pathophysiol Haemost Thromb; 2003; 33(1):16-22. PubMed ID: 12853708
[TBL] [Abstract][Full Text] [Related]
3. Effects of factor VIII inhibitor bypassing activity (FEIBA), recombinant factor VIIa or both on thrombin generation in normal and haemophilia A plasma.
Livnat T; Martinowitz U; Zivelin A; Seligsohn U
Haemophilia; 2008 Jul; 14(4):782-6. PubMed ID: 18371162
[TBL] [Abstract][Full Text] [Related]
4. Elevated factor VIII enhances thrombin generation in the presence of factor VIII-deficiency, factor XI-deficiency or fondaparinux.
Szlam F; Sreeram G; Solomon C; Levy JH; Molinaro RJ; Tanaka KA
Thromb Res; 2011 Feb; 127(2):135-40. PubMed ID: 21144556
[TBL] [Abstract][Full Text] [Related]
5. Combining FVIIa and FX into a mixture which imparts a unique thrombin generation potential to hemophilic plasma: an in vitro assessment of FVIIa/FX mixture as an alternative bypassing agent.
Nakatomi Y; Nakashima T; Gokudan S; Miyazaki H; Tsuji M; Hanada-Dateki T; Araki T; Tomokiyo K; Hamamoto T; Ogata Y
Thromb Res; 2010 May; 125(5):457-63. PubMed ID: 20080285
[TBL] [Abstract][Full Text] [Related]
6. Combination of FVIII and by-passing agent potentiates in vitro thrombin production in haemophilia A inhibitor plasma.
Klintman J; Astermark J; Berntorp E
Br J Haematol; 2010 Nov; 151(4):381-6. PubMed ID: 20977448
[TBL] [Abstract][Full Text] [Related]
7. Antithrombin affects hemostatic response to recombinant activated factor VII in factor VIII deficient plasma.
Szlam F; Taketomi T; Sheppard CA; Kempton CL; Levy JH; Tanaka KA
Anesth Analg; 2008 Mar; 106(3):719-24, table of contents. PubMed ID: 18292408
[TBL] [Abstract][Full Text] [Related]
8. Pro- and anticoagulant factors facilitate thrombin generation and balance the haemostatic response to FEIBA(®) in prophylactic therapy.
Varadi K; Tangada S; Loeschberger M; Montsch P; Schrenk G; Ewenstein B; Turecek PL
Haemophilia; 2016 Jul; 22(4):615-24. PubMed ID: 26879158
[TBL] [Abstract][Full Text] [Related]
9. Recombinant factor VIIa does not induce hypercoagulability in vitro.
Gallistl S; Cvirn G; Muntean W
Thromb Haemost; 1999 Feb; 81(2):245-9. PubMed ID: 10064000
[TBL] [Abstract][Full Text] [Related]
10. The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agents.
van Veen JJ; Gatt A; Bowyer AE; Cooper PC; Kitchen S; Makris M
Int J Lab Hematol; 2009 Apr; 31(2):189-98. PubMed ID: 18190585
[TBL] [Abstract][Full Text] [Related]
11. Factor IX from prothrombin complex concentrate augments low dose tissue factor-triggered thrombin generation in vitro.
Hasan S; Abuelkasem E; Williams B; Henderson R; Mazzeffi MA; Tanaka KA
Br J Anaesth; 2018 Oct; 121(4):936-943. PubMed ID: 30236256
[TBL] [Abstract][Full Text] [Related]
12. Effects of agents, used to treat bleeding disorders, on bleeding time prolonged by a very high dose of a direct thrombin inhibitor in anesthesized rats and rabbits.
Elg M; Carlsson S; Gustafsson D
Thromb Res; 2001 Feb; 101(3):159-70. PubMed ID: 11228339
[TBL] [Abstract][Full Text] [Related]
13. Suppressing protein Z-dependent inhibition of factor Xa improves coagulation in hemophilia A.
Girard TJ; Lasky NM; Grunz K; Broze GJ
J Thromb Haemost; 2019 Jan; 17(1):149-156. PubMed ID: 30451376
[TBL] [Abstract][Full Text] [Related]
14. Reversal of dabigatran effects in models of thrombin generation and hemostasis by factor VIIa and prothrombin complex concentrate.
Hoffman M; Volovyk Z; Monroe DM
Anesthesiology; 2015 Feb; 122(2):353-62. PubMed ID: 25502064
[TBL] [Abstract][Full Text] [Related]
15. Improved coagulation and haemostasis in haemophilia with inhibitors by combinations of superFactor Va and Factor VIIa.
Bhat V; von Drygalski A; Gale AJ; Griffin JH; Mosnier LO
Thromb Haemost; 2016 Mar; 115(3):551-61. PubMed ID: 26466980
[TBL] [Abstract][Full Text] [Related]
16. In vitro evaluation of factor VIII--bypassing activity of activated prothrombin complex concentrate, prothrombin complex concentrate, and factor VIIa in the plasma of patients with factor VIII inhibitors: thrombin generation test in the presence of collagen-activated platelets.
Sultan Y; Loyer F
J Lab Clin Med; 1993 Mar; 121(3):444-52. PubMed ID: 8445292
[TBL] [Abstract][Full Text] [Related]
17. Reversal of the inhibitory effect of fondaparinux on thrombin generation by rFVIIa, aPCC and PCC.
Desmurs-Clavel H; Huchon C; Chatard B; Negrier C; Dargaud Y
Thromb Res; 2009 Mar; 123(5):796-8. PubMed ID: 18771795
[TBL] [Abstract][Full Text] [Related]
18. Feasibility of using thrombin generation assay (TGA) for monitoring bypassing agent therapy in patients with hemophilia having inhibitors.
Ay Y; Balkan C; Karapinar DY; Akin M; Bilenoglu B; Kavakli K
Clin Appl Thromb Hemost; 2013; 19(4):389-94. PubMed ID: 22395575
[TBL] [Abstract][Full Text] [Related]
19. An algal sulfated galactan has an unusual dual effect on venous thrombosis due to activation of factor XII and inhibition of the coagulation proteases.
Melo FR; Mourão PA
Thromb Haemost; 2008 Mar; 99(3):531-8. PubMed ID: 18327401
[TBL] [Abstract][Full Text] [Related]
20. Mechanisms for the anticoagulant effect of heparin and related polysaccharides.
Ofosu FA
Nouv Rev Fr Hematol (1978); 1988; 30(3):155-60. PubMed ID: 2971155
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
